Early production of HIV-1 neutralising antibodies in patients following highly active antiretroviral treatment (HAART) during primary HIV infection.

Barassi, C; De Santis, C; Pastori, C; Marraccini, P; Ciuffreda, D; Capiluppi, B; Bressi, C; Siccardi, A G; Lazzarin, A; Tambussi, G; Lopalco, L

Barassi, C; De Santis, C; Pastori, C; Marraccini, P; Ciuffreda, D; Capiluppi, B; Bressi, C; Siccardi, A G; Lazzarin, A; Tambussi, G; Lopalco, L.

Affiliation

Barassi C; DIBIT and Infectious Disease Clinic, San Raffaele Scientific Institute, Milano, Italy.

J Biol Regul Homeost Agents ; 14(1): 68-74, 2000.

Article in En | MEDLINE | ID: mdl-10763898

Subject(s)

Acquired Immunodeficiency Syndrome/drug therapy; Anti-HIV Agents/therapeutic use; HIV Antibodies/biosynthesis; HIV-1/immunology; Acquired Immunodeficiency Syndrome/immunology; Acquired Immunodeficiency Syndrome/virology; Adult; CD4 Lymphocyte Count; Drug Therapy, Combination; HIV Antibodies/immunology; Humans; Middle Aged; Viremia/drug therapy; Viremia/immunology; Viremia/virology

Search on Google

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: HIV Antibodies / Acquired Immunodeficiency Syndrome / HIV-1 / Anti-HIV Agents Type of study: Guideline Limits: Adult / Humans / Middle aged Language: En Journal: J Biol Regul Homeost Agents Journal subject: BIOLOGIA / BIOQUIMICA Year: 2000 Type: Article Affiliation country: Italy

Search on Google

XML

PubMed Links